NASDAQ:OPUS

Opus Genetics Slides Ahead of June Test

Opus Genetics Slides Ahead of June Test

Opus Genetics shares fell 1.6% to $4.29 late Monday morning, retracing some of Friday’s gains. The company will present at the Jefferies Global Healthcare Conference in New York on June 3. Shares remain up over 100% for the year, though the company continues to post losses and awaits key clinical trial data. Trading volume reached about 288,500 shares, with a market cap near $373 million.
June 1, 2026

Stock Market Today

  • Wise Faces Investigation Over Alleged Money Laundering Controls in Europe
    June 1, 2026, 1:50 PM EDT. UK-based money transfer company Wise is under investigation by Belgian prosecutors over alleged money laundering control failures in its European operations, not its UK business. The probe focuses on suspicions that Wise accounts facilitated around €500 million in suspicious transactions across 30 European countries. Wise, which recently shifted its primary stock listing to the US Nasdaq, stated it is cooperating fully but has not received any formal findings yet. Shares plunged 17.5%, wiping more than £1 billion off its market value. The investigation could affect customer trust and lead to regulatory penalties if oversight lapses are confirmed. Founded in 2011, Wise serves over 19 million customers globally with 4.7 million daily transactions.